The Global Platelet Rich Plasma Market Size accounted for USD 444.5 Million in 2021 and is estimated to garner a market size of USD 1,252.4 Million by 2030 rising at a CAGR of 12.3% from 2022 to 2030. The primary factor driving market growth is the increasing application in numerous medical procedures. In addition, growing application in cosmetic industry is a popular platelet rich plasma market trend that is driving the industry growth. PRP has the potential to grow in cosmetic surgery, with plastic surgeons and dermatologists utilizing the platelets' natural healing properties to improve the appearance and overall wellness of the skin
Platelet Rich Plasma PRP Market Report Key Highlights
Platelet Rich Plasma (PRP) is a substance that promotes healing when injected with the help of cell regeneration. It’s a component of blood that contains special factors or proteins that help blood clotting. Moreover, PRP also contains proteins that support cell growth and are prepared by isolating plasma from blood and concentrating it. The injection of PRP into damaged tissues stimulates the body to grow new healthy cells and promotes healing. These have applications across hair loss, tendon injuries, acute injuries, postsurgical repair, and osteoarthritis.
Global Platelet Rich Plasma (PRP) Market Dynamics
Platelet Rich Plasma Market Report Coverage
|Market||Platelet Rich Plasma Market|
|Platelet Rich Plasma Market Size 2021||USD 444.5 Million|
|Platelet Rich Plasma Market Forecast 2030||USD 1,252.4 Million|
|Platelet Rich Plasma Market CAGR During 2022 - 2030||12.3%|
|Platelet Rich Plasma Market Analysis Period||2018 - 2030|
|Platelet Rich Plasma Market Base Year||2021|
|Platelet Rich Plasma Market Forecast Data||2022 - 2030|
|Segments Covered||By Type, By Origin, By Application, And By Geography
|Regional Scope||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa|
|Key Companies Profiled||APEX Biologix, Arthrex, Inc., Celling BioSciences, Dr. PRP America, LLC, EmCyte Corporation, Glofinn Oy, Johnson & Johnson (DePuy Synthes), Juventix, Stryker, T-Biotechnology (T-LAB), Terumo BCT, Inc., and Zimmer Biomet.|
||Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis|
The rising incidence of orthopedic disorders and sports injuries is driving the market growth. The increasing number of cosmetic surgery procedures simultaneously extending medical applications of platelet rich plasma is propelling the market growth. The increasing number of evidence-based studies for PRP-based wound healing is further bolstering the market value. Furthermore, increasing breadth and use of PRP therapy across Medicare beneficiaries is expected to provide potential opportunities over the forecast period from 2022 to 2030. On the other side, high costs associated with PRP Origins are likely to hinder the growth over the forecast period from 2022 to 2030.
Platelet Rich Plasma Market Segmentation
The worldwide platelet rich plasma market is split based on type, origin, application, and geography.
Platelet Rich Plasma Market By Type
On the basis of type, pure platelet-rich plasma (PRP) has a potential share in terms of value in the global market. The pure PRP contains highly concentrated platelet growth factors with reduced red blood cells. Some of the advantages associated with the pure PRP include accelerated healing process, tissue repair and generation, and improvement in overall function that are factors projected to create demand over the forecast period from 2022 to 2030.
Platelet Rich Plasma Market By Origin
Platelet Rich Plasma Market By Application
Platelet Rich Plasma Market Regional Outlook
The Middle East & Africa (MEA)
North America Platelet Rich Plasma Market Accounted For the Maximum Revenue Share in the Global Market
In 2021, North America held the major share owing to the presence of a high-income population and advance healthcare infrastructure. The major economies of the region including the US and Canada are the major revenue contributors to the regional platelet-rich plasma market. The increasing awareness about platelet-rich plasma treatments, the rising number of cosmetic surgeries, and the active involvement of academic and research institutes in evaluating the application of platelet-rich plasma therapies are boosting the regional market value. The increasing risk of sports injuries among young athletes is additionally expected to support growth over the forecast timeframe from 2022 to 2030. According to the U.S. Centers for Disease Control (CDC), the participation of individuals in sports in the U.S. is continuously rising and around 30 million children and adolescents in the U.S. participate in sports.
Asia-Pacific Platelet Rich Plasma Market Is Projected To Exhibit Fastest Growth over the Forecast Period from 2022 To 2030
Asia Pacific is anticipated to experience the fastest growth with a major CAGR (%) during the estimated period from 2022 to 2030. The rapidly developing economies of the region including China and India are the major revenue contributors to the regional market. The increasing investment in research and development (R&D) activities in order to provide more advance and effective solutions to the end-users are further projected to exhibit growth over the estimated period from 2022 to 2030.
Platelet Rich Plasma Market Players
The global platelet rich plasma companies profiled in the report include APEX Biologix, Arthrex, Inc., Celling BioSciences, Dr. PRP America, LLC, EmCyte Corporation, Glofinn Oy, Johnson & Johnson (DePuy Synthes), Juventix, Stryker, T-Biotechnology (T-LAB), Terumo BCT, Inc., and Zimmer Biomet.
The market size of platelet rich plasma market in 2021 was accounted to be USD 444.5 Million.
The projected CAGR of platelet rich plasma market during the analysis period of 2022 to 2030 is 12.3%.
The prominent players of the global platelet rich plasma market are APEX Biologix, Arthrex, Inc., Celling BioSciences, Dr. PRP America, LLC, EmCyte Corporation, Glofinn Oy, Johnson & Johnson (DePuy Synthes), Juventix, Stryker, T-Biotechnology (T-LAB), Terumo BCT, Inc., and Zimmer Biomet.
North America held the dominating platelet rich plasma during the analysis period of 2022 to 2030.
Asia-Pacific region exhibited fastest growing CAGR for platelet rich plasma during the analysis period of 2022 to 2030.
Rise in the incidence of orthopedic disorders and sports injuries, growing number of cosmetic surgical procedures, and increasing investment in PRP for hair loss treatment drives the growth of global platelet rich plasma market.
Based on type, pure platelet-rich plasma segment is expected to hold the maximum share platelet rich plasma market.